CD74 Protein (AA 73-296)
Kurzübersicht für CD74 Protein (AA 73-296) (ABIN8128058)
Target
Alle CD74 Proteine anzeigenProtein-Typ
Biologische Aktivität
Spezies
Quelle
Applikation
Reinheit
-
-
Proteineigenschaft
- AA 73-296
-
Verwendungszweck
- Active Cluster Of Differentiation 74 (CD74)
-
Sequenz
- Gln73-Met296
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
STABILITY: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Isoelectric Point: 7.9
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute in 10 mM PBS ( pH 7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
-
Buffer
- PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
-
Konservierungsmittel
- Dithiothreitol (DTT), ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin and Dithiothreitol (DTT): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- 4 °C,-80 °C
-
Informationen zur Lagerung
- Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
-
-
- CD74 (HLA-DR-gamma (CD74))
-
Andere Bezeichnung
- CD74
-
Hintergrund
- MHCDG, HLA-DG, HLADG, DHLAG, Ia-GAMMA, HLA class II histocompatibility antigen gamma chain, Ia antigen-associated invariant chain, HLA-DR antigens-associated invariant chain
-
Molekulargewicht
- 38-50kDa
-
UniProt
- P04233
-
Pathways
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Negative Regulation of intrinsic apoptotic Signaling, Cancer Immune Checkpoints
Target
-